Analysis of diferentially expressed protein from primary and recurrent ovarian cancer serum

Asian Pacific Journal of Tropical Medicine

Volumn 5, Issue 7, 2012, Pages 573-576

  Wang, Yuan ^a   Yu, Jin Jin ^a   Zhu, Ting ^a   Xu, Ling ^a   Xu, Ming ^b   Huang, Yu Zheng ^b   Pu, Hong ^a   Yu, Chun Qing ^a  

^a Soochow University   (China)

^b BEIJING HOSPITAL   (China)

Author keywords

Covarian cancer; MALDI TOF MS; Primary; Proteomics; Recurrent; WCX kit

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SCREENING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DOWN REGULATION; EARLY DIAGNOSIS; FEMALE; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; OVARY CANCER; PREDICTION; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; RECURRENT CANCER; SENSITIVITY AND SPECIFICITY; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84861492541     PISSN: 19957645     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1995-7645(12)60101-1     Document Type: Article

References (7)

1. Brazert J, Pietryga M, Szabloński W, Persona-Sliwińska A, Biczysko R Diagnostic value of the morphological ultrasound score system and the serum concentration of CA125 in the diagnosis of malignant ovarian cancer. Gineko1 Po1 2003, 74:1542-1547.
2. Xue FX, Zhao J The diagnosisn of recurrent ovarian cancer. Chin J Pract Gynecol Obsterics 2005, 21(7):385-386.
3. Compagni A, Christofori G Recent advances in research on multistage tumorigenesis. Br J Cancer 2000, 83(1):1-5.
4. Livingston DM, Shivdasani R Toward mechanism-based cancer care. JAMA 2001, 285(5):588-593.
5. Kong F, Nicole WC, Xiao X, He D, Zhang Z, Yu Y, et al. Using proteomic approaches to identify new biom-arkers for detection and monitoring of ovarian cancer. Gynecol Oncol 2006, 100(2):247-253.
6. Wang J, Zhang X, Ge X, Guo H, Xiong G, Zhu Y Proteomic studies of early-stage and advanced ovarian cancer patients. Gynecol Oncol 2008, 111(1):111-119.
7. van der Merwe DE, Oikonomopoulou K, Marshall J, Diamandis EP Mass spectrometry:uncovering the cancer proteome for diagnostics. Adv Cancer Res 2007, 96:23-50.